Hodgkin Lymphoma Content
Anna Sureda, EBMT23: Improvements in outcomes in autologous stem cell transplantation for patients with Hodgkin lymphoma
Dr Anna Sureda, President of the European Society for Blood and Marrow Transplantation (EBMT), summarizes the main take-home messages from her educational session on the latest improvements in autologous stem cell transplantation for patients with Hodgkin lymphoma. These include the introduction of new drugs in the salvage setting such as checkpoint inhibitors, improvements to long-term […]
Stephen Ansell: Hodgkin lymphoma – what are the treatment challenges?
Dr Stephen Ansell (Mayo Clinic, Rochester, MN, USA) discusses the challenges and unmet needs in the front-line treatment of Hodgkin lymphoma. Firstly, as a curable disease in around 75% of patients one challenge is finding a cure in more patients. Secondly, in the patients who are cured, can we minimise long-term complications such as fatigue, fertility […]
Journal articles and more to your inbox
Get the latest clinical insights from touchHAEMATOLOGYSign me up!